HBM Holdings Limited
HBM Holdings Limited (HBMHF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HBMHF · as of Jun 9, 2026
Key Statistics
Explore HBM Holdings Limited Data
hbmhf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
hbmhf competitorsHBMHF
ABOS
ACXP
ANEB
BPTH
CINGStock Performance
Full HistoryAbout HBM Holdings Limited
HBM Holdings Limited is a biopharmaceutical company in the clinical development phase, dedicated to the discovery and advancement of differentiated antibody therapeutics for immunological and oncologi…
what is hbm holdings limited · hbmhf stock overview · hbm holdings limited company profile · who is hbm holdings limited ceo · hbmhf OTC · hbm holdings limited headquarters · hbm holdings limited business segments
About Stock Overview & Key Data
HBM Holdings Limited (HBMHF) is a Healthcare company in the Biotechnology industry, listed on OTC since Mar 24, 2022. As of the latest trading session, HBMHF stock price is $2.52, with a market capitalization of $2.1B. The stock has returned +129.09% over the past 12 months and +0.00% year-to-date.
In fiscal year 2025, HBM Holdings Limited reported revenue of $158.2M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, HBM Holdings Limited (HBMHF) stock price is $2.52. The stock is traded on OTC under the ticker symbol HBMHF. The 52-week range is $1.10 – $2.54.